At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases.
We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases
Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. Our lead program targeting the blood diseases -thalassemia and sickle cell disease has entered clinical testing, and our immuno-oncology programs, focused on CRISPR/Cas9-edited allogeneic CAR-T cell therapies, have the potential to deliver a new generation of cancer therapies to patients.
We are seeking a Senior/Principal Research Associate to join an exciting, fast-growing and well-financed company to develop novel gene editing therapies for serious diseases. The successful candidate will join the Technical Operations (Tech Ops) group at CRISPR Therapeutics, focusing on development of analytical methods for ex vivo genetically modified cells to support the development of gene editing programs. The individual will develop quantitative assays measuring gene editing in target and non-target cells, cell-based assays measuring the expression and the biological functions of specific genes. The successful candidate will independently design, perform, and analyze experiments for multiple preclinical and clinical programs, and will work independently to support process development, product characterization, and technical transfer to CMOs and GMP test labs.
Develop and qualify quantitative assays measuring process impurities
Develop qPCR and cell-based assays measuring gene expression/function, and virus infectious titer
Work with Process Development to generate and analyze process development data to develop an understanding of cellular product critical quality attributes to guide testing and process control strategies
Develop data sets supporting product specification and for qualification and/or validation of cell-based assays at CMOs and GMP test labs
Author technical reports on assay development/optimization and SOPs for assay performance
Analyze and present experimental data
Assess and implement new analytical technologies
MS or BS in life sciences and 5+ years of relevant assay development experience in industry
Experience with flow cytometry and qPCR is preferred
Experience in analytical method development, qualification/validation
Understanding of assay development and qualification per regulatory guidance (USP, ICH)
Hands-on experience in development cell-based assays
Excellent oral and written communication skills
Experience in tech transfer of assays to QC labs
Experience with assay development for immunology or immuno-oncology products
Experience in assay development for cell and gene therapy products
Experience in development of cell-based potency assays
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
Crispr Therapeutics AG